161 related articles for article (PubMed ID: 9920205)
1. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension.
Ritter JM; Barrow SE; Doktor HS; Stratton PD; Edwards JS; Henry JA; Gould S
Hypertension; 1993 Aug; 22(2):197-203. PubMed ID: 8340155
[TBL] [Abstract][Full Text] [Related]
3. Delayed hypotensive effect of the thromboxane A2/prostaglandin H2 receptor antagonist S-1452 in spontaneously hypertensive rats.
Sugimoto KI; Shiga T; Fujimura A
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):594-600. PubMed ID: 10901388
[TBL] [Abstract][Full Text] [Related]
4. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
[TBL] [Abstract][Full Text] [Related]
5. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
6. The role of thromboxane A2 in the altered microvascular reactivity in two-kidney, one-clip hypertension.
Carvalho MH; Fortes ZB; Nigro D; Oliveira MA; Scivoletto R
Endothelium; 1997; 5(3):167-78. PubMed ID: 9272380
[TBL] [Abstract][Full Text] [Related]
7. Ridogrel: a selective inhibitor of the cytochrome P450-dependent thromboxane synthesis.
Vanden Bossche H; Willemsens G; Bellens D; Janssen PA
Biochem Pharmacol; 1992 Feb; 43(4):739-44. PubMed ID: 1540227
[TBL] [Abstract][Full Text] [Related]
8. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
9. Placental transfer of the thromboxane synthetase inhibitor ridogrel in the late-pregnant ewe.
Schneider TJ; Struijk PC; Wallenburg HC
Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):83-7. PubMed ID: 10471147
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).
Circulation; 1994 Feb; 89(2):588-95. PubMed ID: 8313547
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nonendothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats.
Dyer SM; Taylor DA; Bexis S; Hime NJ; Frewin DB; Head RJ
J Vasc Res; 1994; 31(1):52-60. PubMed ID: 8274625
[TBL] [Abstract][Full Text] [Related]
12. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.
Xavier FE; Davel AP; Fukuda LE; Rossoni LV
J Hypertens; 2009 Jun; 27(6):1233-42. PubMed ID: 19337130
[TBL] [Abstract][Full Text] [Related]
13. Ridogrel improves maternal/fetal homeostasis in an ovine model of pregnancy-induced hypertension.
Keith JC; Endo Y; Warwick K; Keith KE; Brugh S; Rowles TK
Prostaglandins; 1994 Mar; 47(3):247-63. PubMed ID: 8016393
[TBL] [Abstract][Full Text] [Related]
14. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
Bourgain RH; Andries R; Decuyper K; De Clerck F
J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
[TBL] [Abstract][Full Text] [Related]
17. The in vitro effect of ridogrel on platelet function in normocholesterolaemic and familial hypercholesterolaemic type IIa subjects.
Naran NH; Chetty N
Thromb Res; 1997 Dec; 88(5):399-407. PubMed ID: 9556227
[TBL] [Abstract][Full Text] [Related]
18. Ridogrel prevents the thromboxane-mediated pressor response and oedema induced by hydrogen peroxide in isolated rabbit lungs.
Corten I; Peeters FA; Rampart M; Bult H; Buyssens N; Herman AG
Eur J Pharmacol; 1991 Aug; 201(1):83-90. PubMed ID: 1794415
[TBL] [Abstract][Full Text] [Related]
19. On the bioisosteric potential of diazines: diazine analogues of the combined thromboxane A2 receptor antagonist and synthetase inhibitor Ridogrel.
Heinisch G; Holzer W; Kunz F; Langer T; Lukavsky P; Pechlaner C; Weissenberger H
J Med Chem; 1996 Sep; 39(20):4058-64. PubMed ID: 8831771
[TBL] [Abstract][Full Text] [Related]
20. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
